TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 27317505

Group type: EXPERIMENTAL
Intervention: Classification-specific treatment (CS)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Non classification-specific treatment (NCs)
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Performance training adherence
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Exercise adherence
Number of subjects: 101
Study: 25288615

Group type: EXPERIMENTAL
Intervention: Parental drinking (either parent drank)
Number of subjects: 2200

Group type: EXPERIMENTAL
Intervention: Both parents drank
Number of subjects: 2200

Group type: EXPERIMENTAL
Intervention: Occasional drinking fathers
Number of subjects: 2200

Group type: EXPERIMENTAL
Intervention: Frequent drinking fathers
Number of subjects: 2200

Group type: EXPERIMENTAL
Intervention: Occasional drinking mothers
Number of subjects: 2200

Group type: EXPERIMENTAL
Intervention: Frequent drinking mothers
Number of subjects: 2200

Group type: COMPARATOR
Intervention: Non-drinking parents
Number of subjects: 2200
Study: 22522759

Group type: EXPERIMENTAL
Intervention: Psychological crisis intervention
Number of subjects: 107

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 107
Study: 20025989

Group type: EXPERIMENTAL
Intervention: Azithromycin 500 mg three days a week for 6 months
Number of subjects: 22

Group type: COMPARATOR
Intervention: Standard of care (SC)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Azithromycin
Number of subjects: 22
Study: 18082517

Group type: EXPERIMENTAL
Intervention: Enoxaparin
Number of subjects: 3910

Group type: COMPARATOR
Intervention: Unfractionated Heparin (UFH)
Number of subjects: 3910

Group type: EXPERIMENTAL
Intervention: Both Enoxaparin and UFH
Number of subjects: 3910
Study: 15572589

Group type: EXPERIMENTAL
Intervention: Older age
Number of subjects: 1343

Group type: EXPERIMENTAL
Intervention: Adjustment for cardiovascular risk factors and morbidity
Number of subjects: 1343

Group type: EXPERIMENTAL
Intervention: Adjustment for cardiovascular morbidity
Number of subjects: 1343

Group type: EXPERIMENTAL
Intervention: Subgroup analysis of 51 men and 45 women with low risk profile and no cardiovascular morbidity
Number of subjects: 1343
Study: 12492726

Group type: COMPARATOR
Intervention: Desloratadine 5 mg single dose
Number of subjects: 0

Group type: COMPARATOR
Intervention: Desloratadine 5 mg once daily for 7 days
Number of subjects: 0

Group type: COMPARATOR
Intervention: Desloratadine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 9618124

Group type: EXPERIMENTAL
Intervention: Energy restriction (4,186 kJ/day to 5,023 kJ/day)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Dietary fat restriction (22 g/day to 26 g/day)
Number of subjects: 80
Study: 7623005

Group type: EXPERIMENTAL
Intervention: Inactivated hepatitis A vaccine (720 ELISA units of hepatitis A antigen per dose)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Inactivated hepatitis A vaccine
Number of subjects: 46

Group type: COMPARATOR
Intervention: Unvaccinated (control)
Number of subjects: 46
Study: 2646089

Group type: EXPERIMENTAL
Intervention: Chlordiazepoxide
Number of subjects: 24

Group type: COMPARATOR
Intervention: Methadone
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 24
Study: 207210

Group type: EXPERIMENTAL
Intervention: TSP (trimethroprim‐sulphacetamide‐polomyxin B) ear drops
Number of subjects: 100

Group type: COMPARATOR
Intervention: Gentamicin (Garamycine) ear drops
Number of subjects: 100

Group type: COMPARATOR
Intervention: Gentamicin
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: TSP
Number of subjects: 100
Study: 31238927

Group type: EXPERIMENTAL
Intervention: Virtual education
Number of subjects: 39

Group type: COMPARATOR
Intervention: Traditional education
Number of subjects: 39
Study: 28957563

Group type: EXPERIMENTAL
Intervention: SB2
Number of subjects: 584

Group type: COMPARATOR
Intervention: INF
Number of subjects: 584
Study: 26251107

Group type: EXPERIMENTAL
Intervention: Spousal caregivers (SCs)
Number of subjects: 236

Group type: COMPARATOR
Intervention: Nonspousal caregivers (NSCs)
Number of subjects: 236

Group type: EXPERIMENTAL
Intervention: Depressed spousal caregivers
Number of subjects: 236

Group type: EXPERIMENTAL
Intervention: Caregivers' depressive symptoms
Number of subjects: 236
Study: 22963594

Group type: EXPERIMENTAL
Intervention: Positive affect and self-affirmation (PA/SA) intervention
Number of subjects: 756

Group type: COMPARATOR
Intervention: Informational control
Number of subjects: 756
Study: 21324929

Group type: EXPERIMENTAL
Intervention: ADVANCE intervention (practising with the anaesthesia mask at home and parental planning and use of distraction)
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: ADVANCE intervention (mask practice and distraction)
Number of subjects: 96
Study: 19188372

Group type: EXPERIMENTAL
Intervention: Campaign to increase awareness and use of condoms
Number of subjects: 0

Group type: COMPARATOR
Intervention: Precampaign data
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Postcampaign data
Number of subjects: 0
Study: 16452558

Group type: COMPARATOR
Intervention: BIG‐IV
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: BIG‐IV (within seven days of admission)
Number of subjects: 122
Study: 14971532

Group type: EXPERIMENTAL
Intervention: 50 mg/day of Pueraria mirifica (Group A)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: 100 mg/day of Pueraria mirifica (Group B)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Pueraria mirifica (both doses)
Number of subjects: 37
Study: 11146522

Group type: EXPERIMENTAL
Intervention: Surgical correction of the dilated PA
Number of subjects: 12
Study: 9469523

Group type: EXPERIMENTAL
Intervention: Flurbiprofen (200 mg orally)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 8195389

Group type: EXPERIMENTAL
Intervention: Mixed inoculum of cold-adapted and wild-type viruses
Number of subjects: 0

Group type: COMPARATOR
Intervention: Wild-type A/Kawasaki virus
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cold-adapted virus only
Number of subjects: 0
Study: 2821080

Group type: EXPERIMENTAL
Intervention: Enalapril (5 mg twice daily, maximum dose = 40 mg/d)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Metoprolol (50 mg twice daily, maximum dose = 400 mg/d)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Metoprolol
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Enalapril
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Enalapril and Metoprolol
Number of subjects: 150
Study: 31453961

Group type: EXPERIMENTAL
Intervention: Ospemifene 60 mg daily
Number of subjects: 631

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 631
Study: 29042000

Group type: EXPERIMENTAL
Intervention: NBR biofeedback
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: NBR biofeedback plus topiramate 50 mg (b.i.d.)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Topiramate 50 mg (b.i.d.)
Number of subjects: 33
Study: 26178748

Group type: EXPERIMENTAL
Intervention: Nerve Growth Factor (NGF) injection into extensor carpi radialis brevis (ECRB) muscle
Number of subjects: 26

Group type: COMPARATOR
Intervention: Isotonic saline injection into extensor carpi radialis brevis (ECRB) muscle
Number of subjects: 26
Study: 24014143

Group type: EXPERIMENTAL
Intervention: 800-1000 kcal meal (Study 1)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Fasted state (Study 1)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: 350 kcal/high-fat meal (Study 2)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: 500 kcal/high-fat meal (Study 2)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: 800-1000 kcal/high-fat meal (Study 2)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Fasted state (Study 2)
Number of subjects: 42
Study: 21166786

Group type: EXPERIMENTAL
Intervention: BEACOPP
Number of subjects: 165

Group type: COMPARATOR
Intervention: ABVD
Number of subjects: 165
Study: 17991805

Group type: EXPERIMENTAL
Intervention: Replacement therapy for SCTD; specific dosage and duration not mentioned.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not applicable; no specific intervention mentioned for control.
Number of subjects: 0
Study: 16259942

Group type: EXPERIMENTAL
Intervention: Habit reversal therapy (HR)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Supportive psychotherapy (SP)
Number of subjects: 30
Study: 15097950

Group type: EXPERIMENTAL
Intervention: Combined examination with mandatory excision of equivocal lesions (arm B)
Number of subjects: 913

Group type: EXPERIMENTAL
Intervention: Combined examination with possibility of digital follow‐up according to clinician's decision (arm C)
Number of subjects: 913

Group type: COMPARATOR
Intervention: Conventional naked‐eye examination (mandatory excision of equivocal lesions) (arm A)
Number of subjects: 913
Study: 11329490

Group type: EXPERIMENTAL
Intervention: 4-methylpyrazole (4-MP) 10-15 mg/kg p.o.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: COMPARATOR
Intervention: Lingonberry juice (no ethanol or methanol)
Number of subjects: 0
Study: 9141607

Group type: EXPERIMENTAL
Intervention: Wrist-applied transtelephonic device (WrTTD)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Precordial transtelephonic device (PrTTD)
Number of subjects: 24
Study: 7962671

Group type: EXPERIMENTAL
Intervention: Bisoprolol hemifumarate (5 to 40 mg)
Number of subjects: 8
Study: 2891536

Group type: EXPERIMENTAL
Intervention: 200 mg oxmetidine
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 400 mg oxmetidine
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 50 mg ranitidine
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 30543668

Group type: EXPERIMENTAL
Intervention: Upfront point-of-care (POC) testing
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Combinations of 3 or more tests
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Combinations with 2 or less tests
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Comprehensive blood results included in combinations
Number of subjects: 28
Study: 27530135

Group type: EXPERIMENTAL
Intervention: 15-caliber coils
Number of subjects: 564

Group type: COMPARATOR
Intervention: 10-caliber coils
Number of subjects: 564
Study: 23703687

Group type: EXPERIMENTAL
Intervention: Web-based psychosocial assessment
Number of subjects: 10

Group type: COMPARATOR
Intervention: Interview-based psychosocial assessment
Number of subjects: 10
Study: 22314016

Group type: EXPERIMENTAL
Intervention: Internet-based smoking cessation intervention
Number of subjects: 16430
Study: 20127563

Group type: EXPERIMENTAL
Intervention: XL-184 (BMS-907351)
Number of subjects: 0
Study: 18998925

Group type: EXPERIMENTAL
Intervention: CTeXplorer tool for visualizing design heterogeneity in clinical trials
Number of subjects: 12
Study: 12494305

Group type: EXPERIMENTAL
Intervention: Dietary counselling on protein restriction (n=63)
Number of subjects: 131

Group type: COMPARATOR
Intervention: Usual dietary advice (Control group, n=68)
Number of subjects: 131
Study: 9735677

Group type: EXPERIMENTAL
Intervention: Folic acid supplementation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Genetic mutations (677 CT and 1298 A‐C)
Number of subjects: 0
Study: 8054436

Group type: EXPERIMENTAL
Intervention: Treatment for Toxoplasma gondii
Number of subjects: 44

Group type: COMPARATOR
Intervention: Untreated or treated for only 1 month
Number of subjects: 44
Study: 2784320

Group type: EXPERIMENTAL
Intervention: Dilute propofol in 5% dextrose
Number of subjects: 100

Group type: COMPARATOR
Intervention: Undiluted propofol
Number of subjects: 100
Study: 4623288

Group type: EXPERIMENTAL
Intervention: Active Diapulse machine emitting pulsed, high-frequency electrical energy
Number of subjects: 40

Group type: COMPARATOR
Intervention: Non-active placebo machine
Number of subjects: 40
Study: 31992301

Group type: EXPERIMENTAL
Intervention: Emergency Department Supportive Care Clinical Decision Support (Support-ED) tool
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Palliative Care and Rapid Emergency Screening (P-CaRES) survey
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Clinical alerts triggered by specific patient scenarios
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Monitoring and feedback on CDS functionality
Number of subjects: 0
Study: 31319637

Group type: EXPERIMENTAL
Intervention: Bupivacaine 0.5% (12.5 mg, 2.5 mL)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Pethidine (1 mg/kg)
Number of subjects: 66
Study: 28178132

Group type: EXPERIMENTAL
Intervention: Subtotal thyroidectomy leaving a unilateral remnant based on the upper pole (Group I)
Number of subjects: 168

Group type: COMPARATOR
Intervention: Subtotal thyroidectomy with bilateral dorsal thyroid tissue remnant (Group II)
Number of subjects: 168
Study: 25963290

Group type: EXPERIMENTAL
Intervention: Platelet-rich fibrin (PRF)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (no guided tissue regeneration techniques)
Number of subjects: 30
Study: 24048551

Group type: EXPERIMENTAL
Intervention: BST‐CarGel treatment (n = 41)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Microfracture treatment alone (n = 39)
Number of subjects: 80
Study: 21639636

Group type: EXPERIMENTAL
Intervention: Culturally Informed and Flexible Family‐Based Treatment for Adolescents (CIFFTA)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Traditional Family Therapy (TFT)
Number of subjects: 28
Study: 19736179

Group type: EXPERIMENTAL
Intervention: Self-treatment of exacerbations with an action plan including prednisolone (with or without antibiotics).
Number of subjects: 142

Group type: COMPARATOR
Intervention: Control group (no self-treatment training).
Number of subjects: 142

Group type: EXPERIMENTAL
Intervention: Self-treatment group.
Number of subjects: 142
Study: 16484554

Group type: EXPERIMENTAL
Intervention: Aged garlic extract
Number of subjects: 0

Group type: COMPARATOR
Intervention: Statin therapy
Number of subjects: 0
Study: 15343110

Group type: EXPERIMENTAL
Intervention: Individual teaching session conducted at discharge by a trained pharmacist
Number of subjects: 59

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 59
Study: 11022814

Group type: EXPERIMENTAL
Intervention: Regularly scheduled follow-up interviews
Number of subjects: 188

Group type: EXPERIMENTAL
Intervention: Delayed Year-2 follow-up interviews
Number of subjects: 188

Group type: COMPARATOR
Intervention: Missed scheduled follow-up interviews
Number of subjects: 188
Study: 9282449

Group type: EXPERIMENTAL
Intervention: Professional cleaning
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Scaling and root planing (in addition to professional cleaning)
Number of subjects: 80

Group type: COMPARATOR
Intervention: No treatment (third group)
Number of subjects: 80

Group type: COMPARATOR
Intervention: No treatment (fourth group)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Professional cleaning (fifth group)
Number of subjects: 80
Study: 8380610

Group type: EXPERIMENTAL
Intervention: Ganciclovir (5 mg/kg every 12 hours for 14 days)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 62
Study: 29034719

Group type: EXPERIMENTAL
Intervention: Tailored Activity Program (TAP)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control
Number of subjects: 20
Study: 28851099

Group type: EXPERIMENTAL
Intervention: 2-ml autologous platelet-rich plasma (PRP) injection
Number of subjects: 156

Group type: COMPARATOR
Intervention: Physical therapy without injection (Control)
Number of subjects: 156
Study: 27372556

Group type: EXPERIMENTAL
Intervention: Self-balance technique (SB group)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Arthroscopy-view technique (AV group)
Number of subjects: 60
Study: 25305376

Group type: EXPERIMENTAL
Intervention: HealthValues Healthy Eating Programme (internet-based intervention)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (not specified in detail)
Number of subjects: 100
Study: 22441004

Group type: EXPERIMENTAL
Intervention: Add-on pioglitazone (DP group)
Number of subjects: 98

Group type: COMPARATOR
Intervention: Add-on sulfonylurea (DS group)
Number of subjects: 98
Study: 20202819

Group type: EXPERIMENTAL
Intervention: 0.2% ropivacaine with clonidine 75 microg
Number of subjects: 60

Group type: COMPARATOR
Intervention: 0.2% ropivacaine with sufentanil 5 microg
Number of subjects: 60
Study: 18486923

Group type: EXPERIMENTAL
Intervention: Monoclonal antibodies targeting adhesion molecules
Number of subjects: 0
Study: 17699341

Group type: EXPERIMENTAL
Intervention: Satavaptan 25 mg
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Satavaptan 50 mg
Number of subjects: 34

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Long-term treatment with Satavaptan
Number of subjects: 34
Study: 12689734

Group type: EXPERIMENTAL
Intervention: Antiretroviral drugs (specific drugs and dosages not mentioned)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Surrogate endpoints (time to virological failure and time to regimen termination)
Number of subjects: 0
Study: 10953651

Group type: EXPERIMENTAL
Intervention: Nasal continuous positive airway pressure (n-CPAP)
Number of subjects: 0
Study: 8923574

Group type: EXPERIMENTAL
Intervention: Moclobemide 300 mg/day
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Moclobemide 450 mg/day
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Moclobemide 600 mg/day
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Moclobemide (all doses)
Number of subjects: 47
Study: 1395879

Group type: EXPERIMENTAL
Intervention: Excision of pilonidal sinus with insertion of a collagen sponge containing Gentamicin and primary suture (group 1)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Excision of pilonidal sinus without applying the Gentamicin-collagen sponge (group 2)
Number of subjects: 40
Study: 2986508

Group type: EXPERIMENTAL
Intervention: Oral acyclovir (400 mg five times daily for 10 days)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study: 30730794

Group type: EXPERIMENTAL
Intervention: Revitalization using blood clot scaffold only
Number of subjects: 22

Group type: COMPARATOR
Intervention: Revitalization using blood clot and PRF
Number of subjects: 22
Study: 30081075

Group type: EXPERIMENTAL
Intervention: Gait retraining
Number of subjects: 23

Group type: COMPARATOR
Intervention: Walking exercise
Number of subjects: 23
Study: 26723241

Group type: EXPERIMENTAL
Intervention: Sunitinib + PCI
Number of subjects: 85

Group type: COMPARATOR
Intervention: Placebo + PCI
Number of subjects: 85
Study: 24655007

Group type: EXPERIMENTAL
Intervention: vodka/tonic (20% v/v)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: white wine (12.5% v/v)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: beer (5.1% v/v)
Number of subjects: 15
Study: 22490620

Group type: EXPERIMENTAL
Intervention: Parent-implemented language intervention (24 biweekly 1-hr sessions for 3 months)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Control group (nontreatment experimental condition)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Parent-implemented language intervention
Number of subjects: 34
Study: 19889887

Group type: EXPERIMENTAL
Intervention: Access to the online system and a training programme for GPs (Group 1)
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Access to the online system and education for the whole practice team (Group 2)
Number of subjects: 112

Group type: COMPARATOR
Intervention: Access to the online system only (Control Group)
Number of subjects: 112
Study: 16928464

Group type: EXPERIMENTAL
Intervention: Personalized exercise intervention
Number of subjects: 146
Study: 16276174

Group type: EXPERIMENTAL
Intervention: Low-calorie PN (20 nonprotein kilocalories per kg per day)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Standard PN (30 nonprotein kilocalories per kg per day)
Number of subjects: 40
Study: 12060512

Group type: EXPERIMENTAL
Intervention: Topical ALA-PDT
Number of subjects: 0
Study: 10450013

Group type: EXPERIMENTAL
Intervention: Prostate-specific antigen (PSA)
Number of subjects: 36
Study: 7587985

Group type: EXPERIMENTAL
Intervention: Methotrexate
Number of subjects: 0

Group type: COMPARATOR
Intervention: Traditional slow‐acting antirheumatics (gold, sulphasalazine, penicillamine)
Number of subjects: 0
Study: 2360741

Group type: EXPERIMENTAL
Intervention: Calcium chloride (10 mg/kg, n = 8)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Calcium gluconate (30 mg/kg, n = 7)
Number of subjects: 15
Study: 74607

Group type: EXPERIMENTAL
Intervention: Real acupuncture
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 90
Study: 31269677

Group type: EXPERIMENTAL
Intervention: High-Intensity Intervention (HI) at 70% of 1RM
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Low-Intensity with Blood Flow Restriction (LI-BFR) at 30% of 1RM
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Low-Intensity without Blood Flow Restriction (LI) at 30% of 1RM
Number of subjects: 18
Study: 27450789

Group type: EXPERIMENTAL
Intervention: Sub‐Tenon's local anesthesia during induction
Number of subjects: 268

Group type: EXPERIMENTAL
Intervention: Sub‐Tenon's local anesthesia during maintenance
Number of subjects: 268

Group type: EXPERIMENTAL
Intervention: Phacoemulsification surgery
Number of subjects: 268
Study: 25975474

Group type: EXPERIMENTAL
Intervention: Targeted temperature management at 33°C
Number of subjects: 686

Group type: EXPERIMENTAL
Intervention: Targeted temperature management at 36°C
Number of subjects: 686

Group type: EXPERIMENTAL
Intervention: NSE levels assessed at 24, 48, and 72 h after return of spontaneous circulation
Number of subjects: 686
Study: 23842536

Group type: EXPERIMENTAL
Intervention: Intranasal ketamine (1 mg/kg)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Intranasal fentanyl (1.5 microgram/kg)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Oral ibuprofen (10 mg/kg)
Number of subjects: 72
Study: 21939716

Group type: EXPERIMENTAL
Intervention: Vi polysaccharide vaccine
Number of subjects: 60000

Group type: COMPARATOR
Intervention: Inactivated hepatitis A vaccine
Number of subjects: 60000
Study: 19361362

Group type: EXPERIMENTAL
Intervention: Integrated traditional Chinese and Western medicine therapy without antibiotics
Number of subjects: 54

Group type: COMPARATOR
Intervention: Imipenem‐cilastatin (0.5 g every eight hours for ten days)
Number of subjects: 54
Study: 16922757

Group type: EXPERIMENTAL
Intervention: LMA-U
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: SS-LM
Number of subjects: 300

Group type: COMPARATOR
Intervention: Cobra-PLA
Number of subjects: 300
Study: 12712780

Group type: EXPERIMENTAL
Intervention: Propofol 1 mg/kg
Number of subjects: 28

Group type: COMPARATOR
Intervention: Thiopentone 2 mg/kg
Number of subjects: 28